Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bladder Cancer

  Free Subscription

20.11.2017

2 Actas Urol Esp
1 Biochem Biophys Res Commun
1 Biomed Res Int
2 BMC Cancer
2 Cancer Cell
1 Cancer Immunol Immunother
1 Cell Death Dis
1 Cell Physiol Biochem
1 Curr Urol Rep
1 Diabetes Res Clin Pract
1 Elife
1 Eur Urol
1 Int J Biol Markers
1 Int J Nanomedicine
1 J Urol
1 Jpn J Clin Oncol
1 Medicine (Baltimore)
2 Nat Rev Urol
1 Oncoimmunology
1 Oncol Lett
2 Sci Rep
1 Urol Oncol
1 Urology
1 World J Urol



    Actas Urol Esp

  1. RODRIGUEZ FABA O, Palou J, Vila Reyes H, Guirado L, et al
    Treatment options and predictive factors for recurrence and cancer-specific mortality in bladder cancer after renal transplantation: A multi-institutional analysis.
    Actas Urol Esp. 2017 Nov 7. pii: S0210-4806(17)30176.
    >> Share

  2. UNDA-URZAIZ M, Fernandez-Gomez JM, Cozar-Olmos JM, Juarez A, et al
    Update on the role of endovesical chemotherapy in nonmuscle-invasive bladder cancer.
    Actas Urol Esp. 2017 Nov 9. pii: S0210-4806(17)30180.
    >> Share


    Biochem Biophys Res Commun

  3. XIAN S, Shang D, Kong G, Tian Y, et al
    FOXJ1 promotes bladder cancer cell growth and regulates Warburg effect.
    Biochem Biophys Res Commun. 2017 Nov 9. pii: S0006-291X(17)32241.
    >> Share


    Biomed Res Int

  4. HU Q, Wang G, Peng J, Qian G, et al
    Knockdown of SIRT1 Suppresses Bladder Cancer Cell Proliferation and Migration and Induces Cell Cycle Arrest and Antioxidant Response through FOXO3a-Mediated Pathways.
    Biomed Res Int. 2017;2017:3781904.
    >> Share


    BMC Cancer

  5. TOLKACH Y, Stahl AF, Niehoff EM, Zhao C, et al
    YRNA expression predicts survival in bladder cancer patients.
    BMC Cancer. 2017;17:749.
    >> Share

  6. TAN WS, Feber A, Dong L, Sarpong R, et al
    DETECT I & DETECT II: a study protocol for a prospective multicentre observational study to validate the UroMark assay for the detection of bladder cancer from urinary cells.
    BMC Cancer. 2017;17:767.
    >> Share


    Cancer Cell

  7. MEEKS JJ, Lerner SP
    Molecular Landscape of Non-Muscle Invasive Bladder Cancer.
    Cancer Cell. 2017;32:550-551.
    >> Share

  8. HURST CD, Alder O, Platt FM, Droop A, et al
    Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency.
    Cancer Cell. 2017;32:701-715.
    >> Share


    Cancer Immunol Immunother

  9. BREYER J, Wirtz RM, Otto W, Erben P, et al
    High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients.
    Cancer Immunol Immunother. 2017 Nov 17. doi: 10.1007/s00262-017-2093.
    >> Share


    Cell Death Dis

  10. LIU JY, Dai YB, Li X, Cao K, et al
    Solute carrier family 12 member 5 promotes tumor invasion/metastasis of bladder urothelial carcinoma by enhancing NF-kappaB/MMP-7 signaling pathway.
    Cell Death Dis. 2017;8:e2691.
    >> Share


    Cell Physiol Biochem

  11. LI HJ, Sun XM, Li ZK, Yin QW, et al
    LncRNA UCA1 Promotes Mitochondrial Function of Bladder Cancer via the MiR-195/ARL2 Signaling Pathway.
    Cell Physiol Biochem. 2017;43:2548-2561.
    >> Share


    Curr Urol Rep

  12. LEIBLICH A
    Recent Developments in the Search for Urinary Biomarkers in Bladder Cancer.
    Curr Urol Rep. 2017;18:100.
    >> Share


    Diabetes Res Clin Pract

  13. DAVIDSON MB, Pan D
    An Updated Meta-Analysis of Pioglitazone Exposure and Bladder Cancer and Comparison to the Drug's Effect on Cardiovascular Disease and Non-Alcoholic Steatohepatitis.
    Diabetes Res Clin Pract. 2017 Nov 13. pii: S0168-8227(17)31438.
    >> Share


    Elife

  14. HALSTEAD AM, Kapadia CD, Bolzenius J, Chu CE, et al
    Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation.
    Elife. 2017;6.
    >> Share


    Eur Urol

  15. LINSCOTT JA, Smith AB, Sammon JD
    Re: Woonyoung Choi, Andrea Ochoa, David J. McConkey, et al. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset. Eur Urol 2017;72:354-65.
    Eur Urol. 2017 Nov 9. pii: S0302-2838(17)30971.
    >> Share


    Int J Biol Markers

  16. POZZI V, Di Ruscio G, Sartini D, Campagna R, et al
    Clinical performance and utility of a NNMT-based urine test for bladder cancer.
    Int J Biol Markers. 2017 Nov 11:0. doi: 10.5301/ijbm.5000311.
    >> Share


    Int J Nanomedicine

  17. SMILOWITZ HM, Tarmu LJ, Sanders MM, Taylor JA 3rd, et al
    Biodistribution of gold nanoparticles in BBN-induced muscle-invasive bladder cancer in mice.
    Int J Nanomedicine. 2017;12:7937-7946.
    >> Share


    J Urol

  18. CHANG SS
    Re: Propensity Score Analysis of Radical Cystectomy versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
    J Urol. 2017;198:1208.
    >> Share


    Jpn J Clin Oncol

  19. NISHIYAMA H
    Asia Consensus Statement on NCCN Clinical Practice Guideline for bladder cancer.
    Jpn J Clin Oncol. 2017 Nov 14:1-4. doi: 10.1093.
    >> Share


    Medicine (Baltimore)

  20. XU Y, Huo R, Chen X, Yu X, et al
    Diabetes mellitus and the risk of bladder cancer: A PRISMA-compliant meta-analysis of cohort studies.
    Medicine (Baltimore). 2017;96:e8588.
    >> Share


    Nat Rev Urol

  21. FELSENSTEIN KM, Theodorescu D
    Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy.
    Nat Rev Urol. 2017 Nov 14. doi: 10.1038/nrurol.2017.
    >> Share

  22. STONE L
    Bladder cancer: Context is key: dual roles of ANGPTL4.
    Nat Rev Urol. 2017 Nov 14. doi: 10.1038/nrurol.2017.
    >> Share


    Oncoimmunology

  23. LE GOUX C, Vacher S, Pignot G, Sibony M, et al
    mRNA Expression levels of genes involved in antitumor immunity: Identification of a 3-gene signature associated with prognosis of muscle-invasive bladder cancer.
    Oncoimmunology. 2017;6:e1358330.
    >> Share


    Oncol Lett

  24. ZHANG HH, Huang B, Cao YH, Li Q, et al
    Role of 5-Aza-CdR in mitomycin-C chemosensitivity of T24 bladder cancer cells.
    Oncol Lett. 2017;14:5652-5656.
    >> Share


    Sci Rep

  25. PENG C, Li A, Wang M
    Discovery of Bladder Cancer-related Genes Using Integrative Heterogeneous Network Modeling of Multi-omics Data.
    Sci Rep. 2017;7:15639.
    >> Share

  26. QU H, Zheng Y, Wang Y, Zhang R, et al
    Global and Regional Effects of Bladder Cancer Risk Associated with Pioglitazone Therapy in Patients with Diabetes.
    Sci Rep. 2017;7:15804.
    >> Share


    Urol Oncol

  27. HERMANS TJN, Voskuilen CS, van der Heijden MS, Schmitz-Drager BJ, et al
    Neoadjuvant treatment for muscle-invasive bladder cancer: The past, the present, and the future.
    Urol Oncol. 2017 Nov 8. pii: S1078-1439(17)30551.
    >> Share


    Urology

  28. GARRIDO-ABAD P, Diaz-Menendez A, Fernandez-Arjona M
    Bladder Herpes Infection in a Patient with Low-Grade Non-Muscle-Invasive Bladder Cancer.
    Urology. 2017 Nov 13. pii: S0090-4295(17)31175.
    >> Share


    World J Urol

  29. MARI A, Campi R, Tellini R, Gandaglia G, et al
    Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature.
    World J Urol. 2017 Nov 16. doi: 10.1007/s00345-017-2115.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016